Value Bridge — ROCHESTER GENERAL HOSPITAL
Current $-53M → Target $-29M (+$23.3M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-52.7M
Current EBITDA
$-29.4M
Target EBITDA
+$23.3M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$5.3M
Payer Mix Optimization
$12.6M
Cost to Collect Reduction
$4.2M
Clean Claim Improvement
$3.2M
Volume & Rate Growth
$21.1M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-53M to $-29M. The highest-impact lever is Volume & Rate Growth at $8.4M probability-weighted.
IC talking point: "We see $23M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $256M in equity value creation."